| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.082 | 0.08 |